← back to search

Hao Huang

Nanjing Forestry University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Acute Myeloid Leukemia Research, MicroRNA in disease regulation, RNA modifications and cancer, and Epigenetics and DNA Methylation.
h-index
42
citations
7,645
works
157
NIH funding
primary concept
email

Recent publications

Epitranscriptomic Regulation of Platinum Resistance via the METTL3-ADAM23 Axis in Ovarian Cancer.
2026cited by 0position: contributordoi
Targeting RPS16 with cinnamaldehyde to suppress cervical cancer: inhibition of the PI3K/AKT pathway and degradation of HPV E6 and E7 proteins
Biochemical Pharmacology 2025cited by 3position: middledoi
Supplementary Methods, Supplementary Figures 1-3, Supplementary Tables 1-9 from DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling
2025cited by 0position: contributordoi
Data from N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase
2025cited by 0position: contributordoi
Supplementary Data from N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase
2025cited by 0position: contributordoi
Data from DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling
2025cited by 0position: contributordoi
Integrated metabolomic and transcriptomic analyses provide insights into regulation mechanisms during bulbous stem development in the Chinese medicinal herb plant, Stephania kwangsiensis
BMC Plant Biology 2024cited by 9position: firstdoi
E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells.
2024cited by 4position: contributordoi
Comparative transcriptomic, epigenomic and immunological analyses identify drivers of disparity in high-grade serous ovarian cancer.
2024cited by 4position: contributordoi
N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase.
2023cited by 14position: contributordoi
DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling.
2023cited by 11position: contributordoi
Supplementary Data from N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase
2023cited by 0position: contributordoi
Supplementary Data from N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase
2023cited by 0position: contributordoi
Data from DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling
2023cited by 0position: contributordoi
Data from N6-Methyladenosine RNA Modifications Regulate the Response to Platinum Through Nicotinamide N-methyltransferase
2023cited by 0position: contributordoi
Supplementary Methods, Supplementary Figures 1-3, Supplementary Tables 1-9 from DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling
2023cited by 0position: contributordoi
Supplementary Methods, Supplementary Figures 1-3, Supplementary Tables 1-9 from DOT1 L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling
2023cited by 0position: contributordoi
Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids
Proceedings of the National Academy of Sciences 2022cited by 93position: middledoi
Ovarian cancer cell fate regulation by the dynamics between saturated and unsaturated fatty acids.
2022cited by 72position: contributordoi
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer
Journal of Clinical Investigation 2022cited by 69position: middledoi
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
2022cited by 60position: contributordoi
The Balance between Saturated and Unsaturated Fatty Acids Regulates Ovarian Cancer Cell Fate
2022cited by 0position: contributordoi
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
2021cited by 200position: contributordoi
Loss of host tissue transglutaminase boosts antitumor T cell immunity by altering STAT1/STAT3 phosphorylation in ovarian cancer.
2021cited by 23position: contributordoi
Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
Cancer Research 2020cited by 245position: middledoi
FTO-Dependent <i>N</i> <sup>6</sup>-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling.
2020cited by 154position: contributordoi
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmC.
2020cited by 52position: contributordoi
High frequency regeneration of plants via callus-mediated organogenesis from cotyledon and hypocotyl cultures in a multipurpose tropical tree (Neolamarkia Cadamba)
Scientific Reports 2020cited by 42position: firstdoi
Frizzled-7 Identifies Platinum Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis
2020cited by 1position: contributordoi
BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells
Nature 2019cited by 142position: middledoi

Grants

2021 NSF Student Poster Competition at the ASME International Mechanical Engineering Congress and Exposition (ASME-IMECE); Virtual; November 1-5, 2021
NSF2135464$19,9002021–2023PIRePORTER
CAREER: Algebraic Methods in Extremal Combinatorics
NSF1945200$56,7182020–2025PIRePORTER
Atlanta Lecture Series in Combinatorics and Graph Theory
NSF1700355$17,8002017–2018PIRePORTER
Atlanta Lecture Series in Combinatorics and Graph Theory
NSF1606418$24,8752016–2017PIRePORTER
Understanding Corrosion and Diffusion Behavior in Metal Particle Polymer Composites for Corrosion Sensing
NSF0800718$265,2692008–2012PIRePORTER

Frequent collaborators

· 14 papers (2023–2026)Daniela E. Matei · Elsevier, Inc.14 papers (2022–2026)Andres Felipe Valdivia · Northwestern University12 papers (2023–2025)Yinu Wang · Northwestern University12 papers (2023–2025)Jianjun Chen · City Of Hope National Medical Center10 papers (2012–2017)Guangyuan Zhao · Imperial College London8 papers (2022–2025)Zejuan Li · Houston Methodist8 papers (2012–2016)Stephen Arnovitz · University of Chicago7 papers (2012–2016)Xi Jiang · Foshan University7 papers (2012–2017)Mary Beth Neilly · University of Chicago6 papers (2012–2016)Horacio Cardenas · Northwestern University6 papers (2023–2025)Yaqi Zhang · American Association for Cancer Research6 papers (2023–2025)Jie Jin · Taiyuan University of Technology6 papers (2015–2020)Sandeep Gurbuxani · University of Chicago6 papers (2012–2016)Yungui Wang · Zhejiang Lab5 papers (2015–2017)Hengyou Weng · First Affiliated Hospital of Guangzhou Medical University5 papers (2015–2017)Chunjiang He · Huazhong Agricultural University4 papers (2012–2013)Shenglai Li · Palo Alto Institute4 papers (2015–2016)Michelle M. Le Beau · Cancer Prevention and Research Institute of Texas4 papers (2012–2016)Rui Su · Wuhan Polytechnic University4 papers (2015–2017)